Colorado law requires prescription drug manufacturers to disclose in writing to Colorado prescribers the Wholesale Acquisition Cost (“WAC”) of marketed drugs when engaging in prescription drug marketing. This disclosure provides the WAC price for the product listed below.
| NDC | Partner Therapeutics Product | Dosage Form | Strength | Unit Size | Wholesale Acquisition Cost |
|---|---|---|---|---|---|
| 71837-1000-02 | BIZENGRI® | Vial | 375mg/18.75mL(20mg/mL) | 2 vial pack | $23,750* |
The price paid by patients to acquire the product listed is often different than the WAC price listed, and most patients do not pay WAC. How much a patient will pay will depend on the patient’s insurance coverage. To find out the exact cost of a prescription, patients should contact their health insurance company or preferred pharmacy.
*Pricing as of January 1, 2025. The pricing information disclosed above represents the WAC price, which represents the manufacturer’s published catalog or list price for a drug product to wholesalers as reported to third-party drug pricing publishers. WAC does not represent actual transaction prices and does not include discounts, rebates or reductions in price. Pricing information listed does not imply safety or efficacy of the product.
BIZENGRI is a registered trademark of Merus, N.L